Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 13, keine Gesamtzahl für „Combination“
Suchtreffer
Begriffe & Kennungen
Cyramza · 4.8 · The most common adverse reactions observed in patients treated with ramucirumab in combination with chemothera
Eintrag öffnenCyramza · 4.8 · The most common adverse reactions observed in patients treated with ramucirumab in combination with erlotinib
Eintrag öffnenCyramza · 4.8 · The most serious adverse reactions associated with ramucirumab treatment (as a single agent or in combination
Eintrag öffnenDNA, rekombinante
Eintrag öffnenDNA-Rekombinationsreparatur
Eintrag öffnenDafiro HCT · 4.8 · In the 8-week controlled clinical study, changes in laboratory parameters observed with the combination of Daf
Eintrag öffnenDafiro · 4.5 · Interactions common to the combination
Eintrag öffnenDafiro · 4.8 · 11 Additional information on the combination
Eintrag öffnenDarunavir Krka · 4.3 · Applicable to darunavir boosted with either ritonavir or cobicistat: The combination product lopinavir/riton
Eintrag öffnenDarunavir Krka · 4.3 · Co-administration with the combination product lopinavir/ritonavir (see section 4.5).
Eintrag öffnenDarunavir Krka · 4.3 · Combination of rifampicin with darunavir with concomitant low dose ritonavir (see section 4.5).
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.3 · Applicable to darunavir boosted with either ritonavir or cobicistat: - The combination product lopinavir/riton
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.3 · Co-administration with the combination product lopinavir/ritonavir (see section 4.5).
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.3 · Combination of rifampicin with darunavir with concomitant low dose ritonavir (see section 4.5).
Eintrag öffnenDarzalex · 4.5 · 8 Clinical pharmacokinetic assessments of daratumumab in combination with lenalidomide, pomalidomide, thalidom
Eintrag öffnenDarzalex · 4.8 · 45 In patients with multiple myeloma receiving intravenous daratumumab combination therapy, the following were
Eintrag öffnenDarzalex · 4.8 · In patients receiving DARZALEX combination therapy, fatal infections (grade 5) were reported as follows: Relap
Eintrag öffnenDarzalex · 4.8 · In patients with AL amyloidosis receiving DARZALEX subcutaneous formulation combination therapy, the following
Eintrag öffnenDarzalex · 4.8 · In patients with multiple myeloma receiving DARZALEX subcutaneous formulation combination therapy, the followi
Eintrag öffnenDarzalex · 4.8 · In study MMY1001, patients receiving daratumumab combination treatment (n=97) were administered the first 16 m
Eintrag öffnen